SEC Filings for Dr. Reddy's Laboratories Ltd (RDY)

$ 52.47   -0.97 (-1.82%) Volume: 140.89k 6:30 PM EDT 1-Jun-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934805/05/2005
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934704/06/2005
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341202/23/2005
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19344202/23/2005
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19344002/23/2005
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/14/2005
SC 13GStatement of acquisition of beneficial ownership by individuals102/14/2005
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934512/07/2004
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19343912/03/2004
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341511/08/2004
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934810/12/2004
20-F/A[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]810/01/2004
20-FRegistration statement / Annual report / Transition report13809/30/2004
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934709/14/2004
282930313233343536373839404142